



Life-long hematopoiesis is established by hundreds of precursors throughout 3 





Miguel Ganuza1, Trent Hall1, David Finkelstein3, Ashley Chabot1, Guolian Kang2 and 9 
Shannon McKinney-Freeman§1. 10 
 11 
 12 
1Department of Hematology, 2Department of Biostatistics and 3Department of 13 
Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, 38105 14 
________________________________________________ 15 
 16 
§ Corresponding author  17 
 2 
Summary  18 
Current dogma asserts that mammalian life-long blood production is established by a 19 
small number of blood progenitors. However, this model is based on assays that require 20 
the disruption, transplantation and/or culture of embryonic tissues. Here, we used the 21 
sample-to-sample variance (SSV) of a multi-colored lineage trace reporter to assess the 22 
frequency of emerging life-long blood progenitors while avoiding the disruption, culture 23 
or transplantation of embryos. We find that approximately 719 Flk-1+ mesodermal 24 
precursors, 633 VE-Cadherin+ endothelial precursors and 545 Vav1+ nascent blood stem 25 
and progenitor cells emerge to establish the hematopoietic system at embryonic days (E) 26 
7-E8.5, E8.5-E11.5 and E11.5-E14.5, respectively. We also determined that the spatio-27 
temporal recruitment of endothelial blood precursors begins at E8.5 and ends by E10.5 28 
and that many c-Kit+ clusters of newly specified blood progenitors in the aorta are 29 
polyclonal in origin. Our work illuminates the dynamics of the developing mammalian 30 
blood system during homeostasis. 31 
 32 
  33 
 3 
Introduction 34 
Hematopoietic stem cells (HSCs) emerge during embryogenesis from mesodermally-35 
derived Runx1+ hemogenic endothelial cells (HE) in the dorsal aorta and arterial 36 
vasculature between embryonic day 10.5 (E10.5) and E11.5 of mouse ontogeny1. From 37 
here, they circulate to the fetal liver (FL), expand, and then seed the bone marrow (BM)1. 38 
Transplantation studies estimate <1 HSC/embryo at E10.5 and between 1-2 39 
HSCs/embryo at E11.52-11. However, live imaging and multi-color fate mapping of 40 
zebrafish HE reveals much greater numbers of phenotypic HSCs and about 30 functional 41 
long-term HSC clones emerging from the mid-gestation dorsal aorta12-14. Recently, the 42 
reaggregation of mouse aorta-gonads-mesonephros (AGM) with BM-derived OP9 43 
stromal cells and limiting dilution transplantation estimated 50 and 70 murine HSC 44 
precursors at E10.5 and E11.5, respectively15. It is impossible to know, however, if 45 
predictions made based on non-physiological ex vivo niches faithfully reflect in vivo HSC 46 
formation. Furthermore, recent work reveals that transplantation likely fails to read out 47 
the full repertoire of cells sustaining life-long hematopoiesis during homeostasis16-18. 48 
Thus, any transplantation-based approach almost certainly underestimates HSC and 49 
precursor numbers. Here, we sought to measure the number of independently specified 50 
precursors contributing to life-long hematopoiesis at distinct stages of mouse ontogeny 51 
using an approach unbiased by transplantation or ex vivo manipulation. We took 52 
advantage of the ROSA26+/Confetti allele (Confetti allele)19, which is recombined by Cre 53 
recombinase (CRE) to label cellular progeny randomly with GFP, YFP, RFP or CFP (i.e. 54 
Confetti-labeled cells) (Fig. 1a). Here, we establish that the SSV in the distribution of 55 
Confetti-colors in murine peripheral blood (PB) correlates with the number of cells 56 
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initially labeled with CRE, either during embryogenesis or in adults. We exploit this 57 
observation to discover that hundreds of precursors emerge throughout mouse ontogeny 58 
to establish life-long hematopoiesis. 59 
 60 
  61 
 5 
Results 62 
SSV in the distribution of Confetti-colors predicts initiating cells in vitro. 63 
Classic studies successfully employed SSV, using the binomial or Poisson models, to 64 
estimate HSC numbers in adult mice20-24. Here, we took a similar approach to analyze the 65 
embryo using the Confetti allele19 (Fig. 1a). This system has been used to visualize the 66 
clonal dynamics of solid tissue stem cells, but has not yet been applied to studies of 67 
hematopoiesis19,25. We hypothesized that the SSV in the distribution of Confetti-colors in 68 
the peripheral blood (PB) would correlate with the number of Confetti-labeled precursors 69 
contributing to life-long hematopoiesis such that large numbers of Confetti+ precursors 70 
would yield a low variance and a small number of Confetti+ precursors would produce a 71 
high variance (Fig. 1b). We tested this hypothesis empirically by generating an 72 
immortalized fibroblast cell line from ROSA26ERT2-Cre/Confetti mice (“inducible Confetti 73 
cells” or iCCs)(Fig. 1c). 4-OHT treatment of iCCs resulted in a distribution of Confetti-74 
colors that was stable and specific to this cell line (Fig. 1d and Supplementary Fig. 1). 75 
Here, the GFP+ allele was under-favored, as has been previously reported19. We plated 76 
replicates of 5-50,000 4-OHT-treated iCCs, expanded these cells in culture, and then 77 
analyzed the distribution of Confetti-colors by flow cytometry (Fig. 1c). The coefficient 78 
of variance (CV, standard deviation/mean) amongst colors and between wells was 79 
calculated for each individual Confetti-color at each plated cell number. As expected, a 80 
decrease in the initial plated cell number correlated with an increase in the observed CV 81 
for each individual Confetti-color (Fig. 1e). From here onwards, CV will refer to the SSV 82 
in the distribution of the Confetti-colors. Next, we examined the average Log10(CV) for 83 
YFP, CFP and RFP versus the Log10(cell number) and observed a linear relationship 84 
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between 50 and 2500 starting cells that yielded the following formula for estimating 85 
starting cell numbers based on SSV: cell number = 10(-1.56(log10CV) + 1.47) (Fig. 1f, see 86 
Methods and Legend for additional details on formula derivation). This formula yielded 87 
accurate starting cell numbers estimates at Confetti labeling efficiencies of >3% and 88 
when >500 cells were analyzed (Fig. 1g-h, Supplementary Table 1). 89 
 90 
SSV in the distribution of Confetti-colors predicts the number of blood precursors in vivo. 91 
To assess if our formula could accurately estimate starting cell numbers when applied to 92 
hematopoiesis, CD45.1+CD45.2+ mice were transplanted with 5x106, 1x106 or 2x105 93 
whole bone marrow (WBM) cells isolated from CD45.2+ ROSA26+/ConfettiVE-94 
Cadherin+/Cre mice (Fig. 2a-b). Because blood derives from endothelium, VE-cadherinCre 95 
labels the entire hematopoietic compartment26. Historically, the frequency of 96 
transplantable WBM HSCs is consistently estimated as about 1/10,00027-33. Thus, we 97 
expected recipients to engraft with about 500, 100 and 20 long-term HSCs (LT-HSCs), 98 
respectively. By 32 weeks post-transplant, in three independent experiments, the 99 
observed Log(CV) of the Confetti-colors in CD45.2+ PB estimated reconstitution with an 100 
average of 592±260, 220±19, and 121±16 LT-HSCs in recipients of 5x106, 1x106 or 101 
2x105 WBM cells, respectively (Fig. 2b, Supplementary Table 2). As 20 initiating events 102 
falls outside our window of precision (Fig. 1f), it is not surprising that our formula did 103 
not accurately estimate this value. The Log(CV) of Confetti-colors in CD45.2+ PB at 104 
earlier time-points post-transplant (4-16 weeks) revealed large numbers of initiating 105 
events (i.e. repopulating units, RUs) in all transplanted mice (Fig. 2b). This number 106 
steadily declined over time in recipients. This pattern reflects the well established gradual 107 
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exhaustion of short-term HSCs and progenitors over time post-transplant 34-36. In a 108 
second experiment, Confetti+ WBM was transplanted at limiting dilution (Fig. 2a, 2c, 109 
Supplementary Fig. 2a-b). Here, the precise input of RUs could be independently 110 
confirmed by limiting dilution analysis (LDA). Our Confetti-based RU estimate 111 
correlated precisely with that predicted via LDA at 20 weeks post-transplant (Fig. 2c, 112 
Supplementary Fig. 2a-b, Supplementary Table 3). These experiments confirm that SSV 113 
in the distribution of Confetti-colors accurately reflects changes in initiating cell numbers 114 
in a reconstituting hematopoietic system. 115 
 116 
Transplantable HSCs in the E11.5 AGM expand dramatically during ex vivo explant 117 
culture37. Thus, we tested if our Confetti approach could detect this increase. One to five 118 
embryo-equivalents (EE) of E11.5 AGM-derived cells were isolated from CD45.2+ 119 
ROSA26+/ConfettiVE-Cadherin+/Cre embryos and transplanted into lethally irradiated 120 
CD45.1+CD45.2+ mice (Fig. 2d). There was significant CD45.2+ engraftment in 6/15 121 
recipients (Fig. 2e). In two of these recipients, the CD45.2+ PB was primarily labeled 122 
with a single Confetti color (Fig. 2f), reflecting engraftment with very few HSCs. 123 
CD45.2+ PB in the remaining recipients was Confetti-, which is consistent with both a 124 
small number of engrafted HSCs and a recombination efficiency of only about 45% in 125 
ROSA26+/ConfettiVE-Cadherin+/Cre mice (Supplementary Fig. 2c). This confirms previous 126 
reports that few newly specified HSCs are detected when transplanted into adult 127 
recipients2-4. E11.5 CD45.2+ ROSA26+/ConfettiVE-Cadherin+/Cre AGMs were next cultured 128 
as explants for three days, dissociated, and then transplanted at 1EE into lethally 129 
irradiated CD45.1+CD45.2+ recipients (Fig. 2d). Here, 7/7 recipients displayed >90% 130 
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CD45.2+ PB, of which 25-65% was Confetti+ (Fig. 2e-f). The resulting average 131 
Log10(CV) of the well-represented Confetti colors of the CD45.2+ PB estimated that 132 
AGM-explant cell recipients were repopulated by 222 HSCs (95% CI[128,384]), Table 1, 133 
Supplementary Table 4, Supplementary Fig. 2d). These data confirm a >150-fold 134 
expansion of HSCs during ex vivo AGM explant culture, as reported previously37. The de 135 
novo appearance of Confetti+ cells in the PB of AGM-explant recipients (Fig. 2f) 136 
indicates that some of this expansion is due to ongoing nascent specification, as 137 
previously reported37. This experiment further confirms that SSV in the distribution of 138 
Confetti colors faithfully reflects changes in initiating cell numbers in vivo.  139 
 140 
We next tested our formula for estimating numbers of initiating cells in a non-transplant 141 
based biological context. Hematopoiesis in adult mice is sustained by thousands of 142 
hematopoietic progenitors16,18. Thus, we utilized tamoxifen (TAM) treated adult 143 
ROSA26ERT2-Cre/Confetti mice as a control for large numbers of PB contributing events, 144 
expecting low SSV of Confetti-colors to reflect large numbers of newly labeled 145 
independent clones (Fig. 3a-b). Four weeks after TAM-treatment, the Confetti+ PB of 146 
ROSA26ERT2-Cre/Confetti mice was approximately 33% CFP, 33% RFP, 3%GFP and 147 
29%YFP in all mature lineages examined (Supplementary Figs. 3a-c). As predicted, the 148 
observed SSV in the Confetti-colors was very low (Fig. 3c, Supplementary Table 4). This 149 
variance yielded an estimate of 8572 initiating events (95%CI[5943,12363]) (Table 1, 150 
Supplementary Table 4). This estimate agrees with recent reports of the highly polyclonal 151 
nature of hematopoiesis during homeostasis in adult mice16,18.  To approximate small 152 
numbers of initiating events, we employed the E2a driver, which is first expressed by 153 
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blastomeres during early murine development (Fig. 3a)38. ROSA26+/ConfettiE2a+/Cre mice 154 
thus represent a control for few initiating events and should yield a large SSV in PB 155 
Confetti-colors. Indeed, the observed variance in the PB of adult ROSA26+/ConfettiE2a+/Cre 156 
mice was very high and yielded an estimate of only 28 initiating events (95% CI[10, 81]) 157 
(Table 1, Fig. 3c, Supplementary Fig. 3a, Supplementary Table 4). Further, the 158 
distribution of Confetti-colors in the blood and other mesodermal, ectodermal, and 159 
endodermal tissues was similar and stochastic in individual ROSA26+/Confetti E2a+/Cre mice, 160 
confirming E2a-Cre activation early in development in very few cells (Supplementary 161 
Figs. 3d-f). Thus, the estimated numbers of initiating events for both ROSA26ERT2-162 
Cre/Confetti and ROSA26+/Confetti E2a+/Cre mice demonstrate that our formula performs as 163 
expected in a biological context. 164 
 165 
Hundreds of embryonic precursors contribute to life-long hematopoiesis 166 
We next sought to measure the number of independently specified precursors 167 
contributing to life-long hematopoiesis at distinct stages of mouse development. HSCs 168 
derive from hemogenic endothelium that is mesodermal in origin1. Thus, we interrogated 169 
the clonal complexity of hematopoietic precursors as they emerge from mesoderm and 170 
endothelium by analyzing the SSV of PB Confetti-colors in cohorts of 171 
ROSA26+/ConfettiFlk1+/Cre (n=7) and ROSA26+/ConfettiVE-Cadherin-Cre+/Cre (n = 12) mice, 172 
which begin to express CRE in the mesoderm at E7 and the endothelium at E8.5, 173 
respectively26,39(Fig. 3a).  We also examined cohorts of ROSA26+/ConfettiVav1+/Cre (n=10) 174 
mice, which express CRE in newly specified hematopoietic stem and progenitor cells 175 
(HSPCs) beginning at E11.5 (Fig. 3a, Fig. 4a-b)40. Confetti-allele recombination 176 
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efficiency ranged from 45% to 80% amongst these mouse strains (Supplementary Fig. 2c, 177 
Table 1). Confetti color distribution in the PB of ROSA26+/ConfettiFlk1+/Cre, 178 
ROSA26+/ConfettiVE-Cadherin+/Cre, and ROSA26+/ConfettiVav1+/Cre mice was similar to that 179 
observed in TAM-treated ROSA26ERT2-Cre/Confetti mice (Supplementary Fig. 3a, c). By 180 
inputing the resulting average Log10(CV) of RFP, YFP, and CFP in the PB of each of 181 
these mouse cohorts into our formula for estimating cell numbers and adjusting for 182 
recombination efficiency, we calculated that approximately 719 (95% CI[713,726]), 633 183 
(95% CI[524,763]) and 545 (95% CI[524,567]) mesodermal precursors, hemogenic 184 
endothelial precursors and newly specified HSPCs contribute to life-long hematopoiesis 185 
during mouse ontogeny, respectively (Fig. 3c, Table 1, Supplementary Table 4). These 186 
estimates were stable for ≥16 weeks of age for all mice (Supplementary Fig. 4d) and fell 187 
well within the cell range in which we empirically demonstrated that SSV in Confetti-188 
colors is a reliable predictor of initiating cell numbers (Fig. 1f, Supplementary Table 1)2-189 
4,15. We did not observe any dramatic differences in the number of precursors 190 
contributing to distinct blood lineages in these strains (Fig. 3f).  191 
 192 
To validate these estimates using an unbiased system, ROSA26+/ConfettiUbiquitin+/ERT2-Cre 193 
mice were subjected to a single dose of TAM at E7.5 (n=5) or E8.5 (n=6) (Fig. 3d). Here, 194 
CRE expression is ubiquitous and can be activated via TAM treatment41. The average 195 
Log10(CV) of RFP, YFP, and CFP in the PB of cohorts of ROSA26+/Confetti 196 
Ubiquitin+/ERT2-Cre mice exposed to TAM at E7.5 and E8.5 yielded, respectively, 197 
estimates of 617 (95% CI[324,1174]) and 538 (95% CI[273,1057]) initiating events 198 
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(Table 1, Supplementary Table 4). These data confirm that hundreds of precursors 199 
present between E7.5-E8.5 and E8.5-E9.5 contribute to life-long hematopoiesis.  200 
 201 
Vav1-Cre drives CRE expression throughout FL hematopoietic ontogeny when FL 202 
HSPCs are thought to expand rapidly42-44. Given that Vav1-Cre labeling of hematopoietic 203 
cells begins at E11.5, we expected Vav1-Cre to capture this expansion and were therefore 204 
surprised that Vav1-Cre yielded similar initiating cell number estimates as Flk-1-Cre and 205 
VE-Cadherin-Cre (Table 1, Supplementary Table 4). One technical explanation for this 206 
result is that Vav1-Cre driven labeling might saturate prior to the expansion of FL 207 
HSPCs. However, Vav1-Cre labeled 80% of adult PB but only about 33% of E13.5 and 208 
E14.5 CD45+c-Kit+ FL cells, suggesting that Vav1-Cre labeling has not yet saturated the 209 
hematopoietic system at these developmental time-points (Supplementary Figs. 2c, Figs. 210 
4a-b). Further, we observed minimal delay in the onset of detectable Confetti 211 
fluorescence in 4-OHT-treated iCCs and recombination of the Confetti allele (Fig. 4c). 212 
However, we did note a slight delay between administration of 4-OHT and detectable 213 
DNA recombination (Fig. 4ci, Supplemental Fig. 6). Thus, altogether these data suggest 214 
the presence of a previously unappreciated developmental bottleneck in the FL, or 215 
temporally downstream of Vav1-Cre-dependent label saturation, that restricts the number 216 
of cells that ultimately establish the final pool of HSPCs that sustain life-long 217 
hematopoiesis. In sum, our data show that 600-700 precursors emerging first from the 218 
mesoderm and then from the endothelium before transiting through the FL ultimately 219 
establish the pool of HSPCs that sustain life-long hematopoiesis.  220 
 221 
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Hemogenic endothelium is specified between E8.5-E10.5 222 
We next sought to define the temporal window when HE precursors are specified. Here, 223 
we employed ROSA26+/ConfettiCdh5+/ERT2-Cre mice, in which CRE activity is activated in 224 
the endothelium by TAM45. The temporal window post-delivery of TAM during which 225 
CRE is active has not been rigorously defined. To estimate this window, 226 
CD45.1+CD45.2+ mice treated with a single dose of TAM were transplanted with 227 
CD45.2+ ROSA26ERT2-Cre /Confetti WBM three, two, one or zero days after treatment (Fig. 228 
5a). Here, Confetti+ PB was only detected in mice transplanted with ROSA26ERT2-Cre 229 
/Confetti WBM on the same day as TAM treatment (Fig. 5bi), despite high CD45.2+ PB 230 
engraftment in all recipients (>90%, Fig. 5bii). Recipients were treated with TAM 12 231 
weeks post-transplant, resulting in 10-40% Confetti+ PB, confirming robust engraftment 232 
of ROSA26ERT2-Cre /Confetti WBM (Fig. 5biii and iv). These data suggest that the effective 233 
window of TAM-mediated Confetti allele recombination following a single treatment 234 
with TAM is <24 hours. Dams pregnant with ROSA26+/ConfettiCdh5+/ERT2-Cre embryos were 235 
treated with a single dose of TAM at E7.5, E8.5, E9.5, E10.5 or E11.5 (Fig. 5c). 236 
Remarkably, 10-24 weeks after birth, Confetti+ cells were mostly observed in the PB of 237 
mice treated with TAM at E8.5 (≈7% Confetti+ PB) and E9.5 (≈8% Confetti+ PB) (Fig. 238 
5d, Fig. 3f), with minimal labeling at E7.5. Labeling abruptly disappeared in the PB of 239 
mice treated with TAM at E10.5 and E11.5 (Fig. 5d), even though yolk sac and AGM 240 
endothelium were clearly labeled (Fig. 5e). Since the window of TAM activity is <24 241 
hours, our data suggest that all HE throughout the embryo that contribute to life-long 242 
hematopoiesis are established by E10.25, after which new recruitment ceases. To test this 243 
further, E11.5 AGMs isolated from CD45.2+ ROSA26+/ConfettiCdh5+/ERT2-Cre embryos 244 
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subjected to TAM at E10.5 were cultured as explants for three days before transplantation 245 
into ablated CD45.2+CD45.1+ recipients (Fig. 5f). We and others have shown that 246 
nascent HSC specification occurs during AGM explant culture (Fig. 2e-f)37. Strikingly, 247 
Confetti labeling was undetectable in the CD45.2+ PB of 4/4 mice transplanted with 248 
AGM explant cells (Fig. 5g), confirming that recruitment of HE ceases before E10.5 and 249 
is not reactivated during AGM explant culture.  The sum of the average estimate of the 250 
frequency of hemogenic precursors contributing to life-long hematopoiesis at E8.5 and 251 
E9.5 is ≈660 (Table 1, Supplementary Table 4). Although the same hemogenic precursor 252 
might be Confetti labeled at both E8.5 and E9.5, this value matches our estimates of the 253 
number of hematopoietic precursors contributing to life-long hematopoiesis gleaned from 254 
ROSA26+/ConfettiFlk1+/Cre, ROSA26+/ConfettiVE-Cadherin+/Cre, and ROSA26+/ConfettiVav1+/Cre 255 
mice.  256 
 257 
Many c-Kit+ intra-aortic clusters are polyclonal.   258 
Finally, we investigated the clonality of intra-aortic hematopoietic clusters (IACs) by 259 
examining the dorsal aorta of E11.5 ROSA26+/ConfettiVE-Cadherin+/Cre mice (Fig. 6a). 260 
Here, among c-Kit+ clusters harboring at least one Confetti color, 38/50 IACs ≥3 261 
cells/cluster were a mixture of unlabeled cells and cells expressing distinct Confetti-262 
colors (Fig. 6b, Supplementary Fig. 4 and 5a). These data suggest a polyclonal origin for 263 
many IACs. As polychromatic IACs could result from ongoing CRE activity, we 264 
examined CRE expression in VE-Cadherin+CD45- Confetti+ and Confetti- cells isolated 265 
from ROSA26+/ConfettiVE-Cadherin+/Cre E8.5 embryos, E9.5 caudal halves or E10.5 AGMs 266 
via qRT-PCR. We observed that CRE mRNA increased from E8.5 to E10.5 267 
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(Supplementary Fig. 5b). To functionally examine the likelihood of ongoing CRE activity 268 
in Confetti+ and Confetti- cells, VE-cadherin+CD45- Confetti-, CFP+, YFP+, or RFP+ 269 
cells were isolated by flow cytometry from E10.5 ROSA26+/ConfettiVE-Cadherin+/Cre 270 
embryos, cultured for seven days, and then analyzed for Confetti-labeling 271 
(Supplementary Fig. 5c and d). Cultured Confetti- cells remained Confetti- 272 
(Supplementary Fig. 5d). Expanded YFP+, CFP+, and RFP+ cultures were composed 273 
nearly entirely of cells expressing the original Confetti-color plated (Supplementary Fig. 274 
5d). These data suggest that color identity is fixed by E10.5 and are consistent with the 275 
idea that polyclonal clusters do not result from ongoing CRE activity post-specification. 276 
However, to definitively rule out this possibility, we examined c-Kit+ IACs in E11.5 277 
ROSA26+/ConfettiCdh5+/ERT2-Cre embryos treated with TAM at E7.5 and E8.5. Here, we also 278 
observed clusters composed of a mixture of unlabeled and Confetti+ cells, further 279 
supporting that many IACs are polyclonal (Fig. 6a).  280 
 281 
  282 
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Discussion 283 
Recent studies have taken advantage of multicolor labeling to study unappreciated blood 284 
properties13,46. In zebrafish, a brainbow-based zebrabow system revealed that 30 HSC 285 
clones are present during peak production from aortic endothelium. Here, we analyze the 286 
clonal complexity of the emerging mammalian hematopoietic system using an approach 287 
that avoids transplantation, disruption or culture of the developing embryo. We  observed 288 
that, within a defined range of initiating events (Fig. 1f), a linear relationship exists 289 
between the SSV in the distribution of Confetti allele-driven colors and the number of 290 
initially labeled cells. Via this approach, we estimated that between 600-700 291 
developmental precursors contribute to life-long hematopoiesis. This is far greater than 292 
previous estimates of the frequency of HSC and HSPC precursors in the E10.5 and E11.5 293 
AGM2-11,15. However, our data are consistent with the large number of IACs observed in 294 
E10.5 embryos (609±84 c-Kit+ cells in the dorsal aorta and about 300 in the vitelline and 295 
umbilical arteries)47. Our findings also agree with the rapid expansion (i.e. 200-fold) of 296 
nascent HSPCs during AGM explant culture (Fig. 2f, Table 1)37. Importantly, AGM 297 
explant culture likely underestimates this potential, as explant culture conditions are 298 
almost certainly sub-optimal relative to the in vivo specification niche. Further, 299 
transplantation-based methods of estimation yield a snap-shot view of the frequency of 300 
functional HSCs at a given point in time, while our approach captures the cumulative 301 
formation of nascent HSPCs that emerge and then exit the AGM. Perhaps more 302 
importantly, our approach did not require an artificial ex vivo niche or nascent HSCs to 303 
repopulate adult recipients. Indeed, newly specified E9.5 yolk sac and E10.5 AGM 304 
HSPCs are more readily functionally detected when transplanted into neonatal, rather 305 
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than adult mice48-51. These studies strongly suggest that many nascent HSPCs have not 306 
yet acquired the ability to robustly engraft the adult BM microenvironment.  307 
 308 
We also report that the specification of HE from endothelium occurs between E8.5 and 309 
E10.5 of murine development, after which it abruptly quenches and cannot be 310 
reactivated. Recent reports in zebrafish suggest the presence of an active cellular niche 311 
promoting the specification of nascent HSCs from the HE52. Our data suggest that a 312 
similar niche may also exist during mammalian development. It would be interesting to 313 
explore whether the abrupt quenching of HE specification results from an active 314 
mechanism of suppression or the passive loss of critical signals that cease or become 315 
distal as the embryo develops and grows.  316 
 317 
Our study exposed several unexpected layers of active regulation of hematopoietic 318 
development. Importantly, our data suggest the presence of a developmental bottleneck in 319 
or downstream of the FL that restricts the number of cells contributing to life-long 320 
hematopoiesis. We speculate that this “bottleneck” could represent finite niche space 321 
capable of supporting the expanding FL HSPC pool or early BM. Further, the polyclonal 322 
nature of many IACs suggests that the cells that form these clusters may be highly 323 
migratory (i.e. IACs may result from the migration and coalescence of multiple nascent 324 
HSPC throughout the dorsal aorta or other sites of active hematopoietic specification). 325 
Interestingly, clusters composed of only two cells (and labeled with at least one Confetti-326 
color) were nearly always monoclonal (25/27, Fig. 6b), suggesting that many nascent 327 
HSPCs divide shortly after specification from HE before incorporating into larger IACs. 328 
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Although it was recently demonstrated that some cluster-derived cells are functional 329 
HSCs in vivo, more work is required to determine if each cell within a cluster contributes 330 
to life-long hematopoiesis53.  331 
 332 
In sum, our data reveal unexpected layers of active regulation of hematopoietic 333 
development, including a developmental bottleneck in or downstream of the FL and an 334 
abrupt quenching in the recruitment of hemogenic endothelium. Remarkably, we reveal 335 
that life-long mammalian hematopoiesis is founded by hundreds of mesodermal and 336 
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                         Table 1. Estimates of initiating cell numbers 



















 E11.5 AGM 
explant; 
endothelium 
- Blood of 
transplant 
recipients 
67 7-0.334 45 
 
7222 128 – 384 
ROSA26ERT2-Cre Adult mice; 
labels all cell 
types 
Adults Adult blood 7 -1.073 16 88572 5943 – 12,363 
E2aCre Pre-implantation; 
labels all cell 
types 




- Adult blood 7 -0.77 66 8719 713– 726 
VE-Cadherin-
Cre 
Endothelium - Adult blood 12 -0.626 45 8633 524– 763 
Vav1Cre HSPCs post-
specification 
 Adult blood 10 -0.75 80 8545 524 - 567 
UbiqERT2-Cre Ubiquitous E7.5 Adult blood 5 -0.26 12 9617 324-1174 
UbiqERT2-Cre Ubiquitous E8.5 Adult blood 6 -0.23 13 9538 273-1057 
Cdh5ERT2-Cre  Endothelium E8.5 Adult blood 5 -0.172 16 9341 161 – 723 
Cdh5ERT2-Cre  Endothelium E9.5 Adult blood 7 -0.152 16 9319 147 – 691 
1Number of mice, embryos, or transplant recipients 544 
2GFP is excluded from all analyses, because GFP+ PB cells always fell below the minimum threshold for precision  545 
3CRE efficiency calculated as % labeling of the total PB 546 
4Estimates normalized to CRE efficiency = (10(-1.56*Log10(CV)+1.47))/(efficiency/100) 547 
595% confidence interval calculated as: (10(-2.1*Log10(CV)+1.06)) – (10(-1.02*(Log10(CV)+1.89)) 548 
6Seven independent explants transplanted into seven recipients 549 
716 weeks post-transplant 550 
8Based on analysis of mice between 10 and 16 weeks of age of both sexes 551 
9Based on analysis of mice at 10 weeks of age of both sexes 552 


































Figure 1. Sample-to-sample variance reliably estimates number of initiating 586 
events  587 
 a, Schematic of Confetti allele. b, Sample-to-sample variance in the distribution of 588 
Confetti colors (output) inversely correlates with initiating events (input). c, 589 
Schematic of iCC experiment. d, Confetti labeling of 4-OHT treated iCCs. e, Well-to-590 
well coefficient of variance (CV, standard deviation/mean) of each Confetti color in 591 
expanded iCCs. f, Average Log10(CV) of RFP, CFP, and YFP vs. Log10(cells 592 
plated/well). Shaded region indicates cell range in which slope minimally diverged 593 
from slope of Log10(CV) vs. Log10 (starting cell number) line yielded in simulations 594 
(50-2500 cells, Supplemental Fig. 1c). Linear regression yielded: cell number =  595 
10(-1.56*Log10(CV)+1.47) with 95% confidence intervals defined by cell number =  596 
10(-2.1*Log10(CV)+1.06) (lower bound) and cell number = 10(-1.02*(Log10(CV)+1.89) (upper 597 
bound).  This linear regression had an R2 of 0.75 and an adjusted R2 of 0.73 and p-598 
value <0.00001 (F(1,13) == 39.21). For the 15 residuals within the range tested the 599 
skew was 0.06 and the kurtosis 2.34, where a perfectly normal distribution would 600 
have a skew of 0 and a kurtosis of three. d, e, f, Results represent 3 independent 601 
similar experiments. g, Labeling efficiency of iCCs treated with different 602 
concentrations of 4-OHT. Error bars indicate ±s.d. of mean (n=9). This experiment 603 
was repeated twice.  h, Confetti-based estimates were normalized to labeling 604 
efficiency as follows: Total initiating events = Estimate*(100/%Confetti+ cells). The 605 
resulting reporter labeling efficiencies were grouped into four categories (3%, 17%, 606 
40-45% and 67-78%). The average Confetti-based estimate of numbers of initially 607 
plated cells after normalization is shown (error bars indicate ± s.d. of mean). 608 
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Confetti-based estimates of numbers of initiating events maintains fidelity when the 609 
labeling efficiency is >3% and >500 cells are examined. Estimates were obtained 610 
from n≥9 plated replicates. Results represent two independent similar experiments. 611 
 612 
Figure 2. Mouse-to-Mouse peripheral blood Confetti variance reliably 613 
estimates number of repopulating units after 614 
transplantation 615 
a, Experimental schematic.  Here, “+/Cre” refers to any mouse heterozygous for CRE. 616 
b, 5x106 , 1x106 , 2x105 ROSA26 +/ConfettiVE-Cadherin+/Cre WBM cells were transplanted 617 
into irradiated mice. Sample-to-sample variance in the PB Confetti colors estimated 618 
the number of repopulating units (RUs). Confetti estimate of RU relative to expected 619 
number of RU based on historical controls (i.e. 1 LT-HSC/10,000 WBM cells). Data 620 
are the average of 3 independent experiments (Supplementary Table 2). Error bars 621 
= s.d. c, CD45.2+ ROSA26+/ConfettiFlk1+/Cre WBM was transplanted at limiting dilution 622 
into irradiated CD45.1+CD45.2+ mice along with 2x105 CD45.1+ WBM cells. Confetti 623 
colors in the CD45.2+ PB was examined between 4-20 weeks post-transplant, along 624 
with the distribution of total CD45.2+ PB chimerism (see Supplementary Fig. 2a-b). 625 
LDA indicates 1 RU/18,320 WBM cells transplanted (yellow bars, Supplementary 626 
Fig. 2b). Confetti-based estimates of RUs is shown at 4, 10, 16 and 20 weeks post-627 
transplant. Error bars in LDA bar represent standard error. For Confetti-based 628 
estimates, error bars represent the 95% CI (Supplementary Table 3). d, 629 
Experimental schematic. CD45.2+ ROSA26+/ConfettiVE-Cadherin+/Cre cells from E11.5 630 
AGM (n=16) or E11.5 AGM explants (n=7) were transplanted into irradiated 631 
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CD45.1+CD45.2+ mice along with 2x105 CD45.1+ WBM cells . e, %CD45.2+ PB 16 632 
weeks post-transplantation. Each circle is an individual recipient. f, Frequency of 633 
unlabeled and Confetti+ cells within CD45.2+ PB of recipients. Each bar is an 634 
individual recipient (Supplementary Table 4).  635 
 636 
Figure 3. Estimate of hematopoietic precursor numbers and activity during 637 
distinct stages of hematopoietic development 638 
a, Schematic of window and site of CRE activity during murine development for 639 
E2aCre, Flk1Cre, VE-CadherinCre and Vav1Cre. ROSA26ERT2-Cre was activated by TAM in 640 
adult mice. b, +/Cre mice were mated with ROSA26Confetti/Confetti and the resulting 641 
adult offspring analyzed by flow cytometry for Confetti labeling. c, Log10(CV) of 642 
each Confetti color in ROSA26+/Confetti+/Cre mice. GFP is excluded because it 643 
represented <10% PB (Supplementary Table 4). d, 10 week old 644 
ROSA26+/ConfettiUbiquitin+/ERT2-Cre mice were analyzed for Confetti label after exposure 645 
to a single dose of TAM at E7.5 (n=5) or E8.5 (n=6). e, Log10(CV) of each Confetti 646 
color in ROSA26+/Confetti Ubiquitin+/ERT2-Cre mice. GFP is excluded because it 647 
represented <10% PB (Supplementary Table 4). f, The number of precursors 648 
generating Myeloid (M), B-cells (B) and T-cells (T) are depicted in parallel to the 649 
global estimate (total white blood cells, WBC) in PB of adult (age indicated in weeks) 650 
ROSA26+/ConfettiFlk1+/Cre, ROSA26+/ConfettiVE-Cadherin+/Cre, and ROSA26+/ConfettiVav1+/Cre 651 
mice.  ROSA26+/Confetti Ubiquitin+/ERT2-Cre  and ROSA26+/ConfettiCdh5+/ERT2-Creanimals 652 
exposed to TAM at different embryonic stages are also shown (Supplementary Table 653 
4).  654 
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 655 
Figure 4. Onset of Confetti labeling in ROSA26+/Confetti Vav1+/Cre embryos.  656 
a, Representative Confetti analysis of CD45+Lineage-c-Kit+ E14.5 657 
ROSA26+/ConfettiVav1+/Cre FL cells. RFP+CFP+ cells likely result from residual 658 
fluorophore protein previously expressed from same cassette before it “flipped” to 659 
allow expression of second fluorophore. b, Confetti labeling in CD45+ cells of the FL, 660 
AGM, and yolk sac of E11.5 (n=5) and CD45+c-Kit+ cells of E12.5 (n=3), E13.5 661 
(n=13), and E14.5 (n=11) ROSA26+/ConfettiVav1+/Cre embryos (Supplementary Table 662 
5). c, To assess the temporal delay between allele recombination and detectable 663 
fluorescence, iCCs treated with 4-OHT were monitored from 0 to 96 hours post-664 
treatment by genomic PCR (i) and flow cytometry (ii). The average of % of Confetti+ 665 
cells is shown (error bars indicate ± s.d. of mean) (n=3) (Supplementary Table 5). 666 
Single arrow in (i) indicates recombined Confetti allele and double arrow in (i) 667 
indicates Cre allele as a control for gDNA content. Numbers indicate biological 668 
replicates. See Supplementary Fig. 6 for unprocessed scan of the gel. 669 
 670 
Figure 5. Hemogenic endothelium is specified between E8.5 and E10.5 of 671 
murine ontogeny.  672 
a, Experimental schematic. ROSA26ERT2-Cre /Confetti (CD45.2+) WBM was transplanted 673 
into irradiated CD45.1+CD45.2+ mice treated with a single dose of TAM at 3, 2, 1, or 674 
0 days pre-transplant (n=4 for each time-point). Recipients were treated again with 675 
five doses of TAM 12 weeks post-transplant. b, i) Confetti label in CD45.2+ PB of 676 
transplant recipients 4 weeks post-transplant. ii) CD45.2+ PB cells in transplant 677 
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recipients 4 weeks post-transplant. iii) Confetti label in PB of transplant recipients 678 
treated again with TAM 12 weeks post-transplant. iv) PB CD45.2+ cells of transplant 679 
recipients treated again with TAM 12 weeks post-transplant. c, 10 week old 680 
ROSA26+/ConfettiCdh5+/ERT2-Cre mice were analyzed for Confetti label after exposure to a 681 
single dose of TAM at E7.5 (n=6), E8.5 (n=5), E9.5 (n=7), E10.5 (n=5) and E11.5 682 
(n=3, which were 0.03, 0.69, 0.3% Confetti+ of total white cells). ≥Two independent 683 
litters were analyzed in each cohort. d, % Confetti label at 10 weeks of age in PB 684 
lineages of ROSA26+/ConfettiCdh5+/ERT2-Cre mice exposed to TAM during gestation. Error 685 
bars indicate ± s.d. of mean (Supplementary Table 5). e, Confetti labeling in VE-686 
Cadherin+ endothelial cells in the AGM and YS; and in adult PB cells isolated from 687 
ROSA26+/ConfettiCdh5+/ERT2-Cre mice exposed to TAM during gestation (Supplementary 688 
Table 5). f, Dams pregnant with CD45.2+ ROSA26+/ConfettiCdh5+/ERT2-Cre embryos were 689 
treated with a single dose of TAM at E10.5. At E11.5, AGMs were collected (n=4), 690 
cultured as explants, and then transplanted. g, %CD45.2+ and %CD45.2+Confetti+ 691 
PB of recipients of ROSA26+/ConfettiCdh5+/ERT2-Cre AGM explant cells four weeks post-692 
transplant (Supplementary Table 5). 693 
 694 
Figure 6. Intra-aortic cell clusters are polyclonal in origin.  695 
a, Analysis of c-Kit+Confetti+ intra-aortic clusters in E10.5 and E11.5 AGMs isolated 696 
from ROSA26+/ConfettiVE-Cadherin+/Cre embryos or ROSA26+/ConfettiCdh5+/ERT2-Cre 697 
embryos exposed to TAM at E7.5 and E8.5 of gestation. b, E10.5 and E11.5 698 
ROSA26+/Confetti VE-Cadherin+/Cre intra-aortic clusters classified by size and cell 699 
composition. (2-cell clusters, n=56; 3-cell clusters, n=16; 4-cell clusters, n=28; 5-cell 700 
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clusters, n=8; 6-cell clusters, n=10; 7-cell clusters, n=3; 8-cell clusters, n=5; ≥8-cell 701 
clusters, n=4) (Supplementary Table 5).    702 
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